SCM

Sterling Capital Management Portfolio holdings

AUM $6.83B
1-Year Est. Return 19.78%
This Quarter Est. Return
1 Year Est. Return
+19.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.04B
AUM Growth
+$592M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,464
New
Increased
Reduced
Closed

Top Buys

1
+$77.4M
2
+$72.3M
3
+$54M
4
WM icon
Waste Management
WM
+$49.6M
5
AFL icon
Aflac
AFL
+$48.4M

Top Sells

1
+$77.1M
2
+$65.3M
3
+$56.9M
4
CVX icon
Chevron
CVX
+$53.1M
5
ELV icon
Elevance Health
ELV
+$44.5M

Sector Composition

1 Technology 25.19%
2 Financials 17.95%
3 Industrials 12.19%
4 Healthcare 9.59%
5 Consumer Discretionary 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPS
3201
DELISTED
Altus Power
AMPS
– –
-1,309
PDCO
3202
DELISTED
Patterson Companies, Inc.
PDCO
– –
-1,124
FNA
3203
DELISTED
Paragon 28, Inc.
FNA
– –
-49
FFNW
3204
DELISTED
First Financial Northwest, Inc
FFNW
– –
-121
ENFN
3205
DELISTED
Enfusion, Inc.
ENFN
– –
-50
BECN
3206
DELISTED
Beacon Roofing Supply, Inc.
BECN
– –
-132
BERY
3207
DELISTED
Berry Global Group, Inc.
BERY
– –
-14,302
LGF.A
3208
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
– –
-1,028
LGF.B
3209
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
– –
-2,148
QVCGB
3210
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
– –
0
CLYM
3211
Climb Bio
CLYM
$131M
– –
-479
ARTV
3212
Artiva Biotherapeutics
ARTV
$97.2M
– –
-158
SKYE icon
3213
Skye Bioscience
SKYE
$47.1M
– –
-292
CTNM
3214
Contineum Therapeutics
CTNM
$335M
– –
-78
BOLD
3215
Boundless Bio
BOLD
$27.5M
– –
-119
GCTS
3216
GCT Semiconductor Holding
GCTS
$81M
– –
-8
QTTB icon
3217
Q32 Bio
QTTB
$29.6M
– –
-105
SMXT icon
3218
Solarmax Technology
SMXT
$55.4M
– –
-302
TELO icon
3219
Telomir Pharmaceuticals
TELO
$45.7M
– –
-148
MGX icon
3220
Metagenomi
MGX
$69.8M
– –
-190
KYTX icon
3221
Kyverna Therapeutics
KYTX
$317M
– –
-186
STI icon
3222
Solidion Technology
STI
$78.4M
– –
0
GUTS icon
3223
Fractyl Health
GUTS
$149M
– –
-237
ANRO icon
3224
Alto Neuroscience
ANRO
$439M
– –
-161
FBLG icon
3225
FibroBiologics
FBLG
$16.9M
– –
-26
127 128
129
130 131